Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic

被引:20
作者
Hirao, Chieko [1 ]
Mikoshiba, Naoko [1 ]
Shibuta, Tomomi [1 ]
Yamahana, Reiko [1 ]
Kawakami, Aki [1 ]
Tateishi, Ryosuke [2 ]
Yamaguchi, Hironori [3 ]
Koike, Kazuhiko [2 ]
Yamamoto-Mitani, Noriko [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Gerontol Home Care & Long Term Care Nursing, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Tochigi, Japan
关键词
gastroenterological cancer; medication adherence; oral chemotherapy medications; outpatients; ANTINEOPLASTIC AGENTS; THERAPY; NONADHERENCE; DETERMINANTS; MORTALITY; COHORT; WOMEN;
D O I
10.1093/jjco/hyx087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of this study was to investigate medication adherence to oral chemotherapy medications and determinants of medication non-adherence to them among gastroenterological cancer patients. Methods: A cross-sectional study was conducted on 117 consecutive, consenting, eligible patients visiting an outpatient clinic of university hospital in Japan. Good medication adherence was defined as taking 100% of the prescribed dose. Medication adherence was measured via self-report. We hypothesized that there was a significant relationship between medication non-adherence and the five factors defined by the World Health Organization: patient-related, socioeconomic-related, condition-related, treatment-related, and healthcare-system/provider-related factors. Multiple logistic regression models were used to identify factors associated with oral chemotherapy medication non-adherence. Results: The proportion of patients showing good medication adherence was 56.4%. The multiple logistic regression analysis revealed that the determinants of medication non-adherence to oral chemotherapy medications included having a history of patient-caused treatment interruptions due to worsening of symptoms (adjusted odds ratio [AOR] = 9.59, 95% confidence interval [CI] = 1.38-66.47), having diarrhea (AOR = 3.25, 95% CI = 1.13-9.34), experiencing pain (AOR = 0.17, 95% CI = 0.05-0.55), taking oral chemotherapy medication every 8 h (AOR = 5.52, 95% CI = 1.71-17.81), and diminished sense of priority for medication (AOR = 1.40, 95% CI = 1.21-1.63). Conclusions: This study suggests that many patients with gastroenterological cancer were non-adherent to oral chemotherapy medications. It might be necessary to conduct periodic screening and connect patients at a high risk of medication non-adherence to appropriate support.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 50 条
[21]   Identifying adherence barriers to oral endocrine therapy among breast cancer survivors [J].
Paranjpe, Rutugandha ;
John, Grace ;
Trivedi, Meghana ;
Abughosh, Susan .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) :297-305
[22]   Influencing Factors on Medication Adherence in Colorectal Cancer Patients Receiving Oral Chemotherapy [J].
Kim, Jeong Hye .
ASIAN ONCOLOGY NURSING, 2012, 12 (03) :213-220
[23]   A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof-of-concept trial [J].
Ross, Xiomara Skrabal ;
Gunn, Kate M. ;
Suppiah, Vijayaprakash ;
Patterson, Pandora ;
Boyle, Terry ;
Carrington, Christine ;
Tan, Shir Ley ;
Ryan, Marissa ;
Joshi, Rohit ;
Olver, Ian .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) :E378-E387
[24]   Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review [J].
Zullig, Leah L. ;
Drake, Connor ;
Shahsahebi, Mohammad ;
Avecilla, Renee A. V. ;
Whitney, Colette ;
Mills, Coleman ;
Oeffinger, Kevin C. .
JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (03) :595-618
[25]   Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review [J].
Leah L. Zullig ;
Connor Drake ;
Mohammad Shahsahebi ;
Renee A. V. Avecilla ;
Colette Whitney ;
Coleman Mills ;
Kevin C. Oeffinger .
Journal of Cancer Survivorship, 2023, 17 :595-618
[26]   Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine [J].
Elsous, Aymen ;
Radwan, Mahmoud ;
Al-Sharif, Hasnaa ;
Abu Mustafa, Ayman .
FRONTIERS IN ENDOCRINOLOGY, 2017, 8
[27]   Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension [J].
Natarajan, Nandini ;
Putnam, Wayne ;
Van Aarsen, Kristine ;
Lawson, Beverley ;
Burge, Fred .
CANADIAN FAMILY PHYSICIAN, 2013, 59 (02) :E93-E100
[28]   Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients [J].
Mazzaglia, Giampiero ;
Ambrosioni, Ettore ;
Alacqua, Marianna ;
Filippi, Alessandro ;
Sessa, Emiliano ;
Immordino, Vincenzo ;
Borghi, Claudio ;
Brignoli, Ovidio ;
Caputi, Achille P. ;
Cricelli, Claudio ;
Mantovani, Lorenzo G. .
CIRCULATION, 2009, 120 (16) :1598-U82
[29]   A review on adherence management in patients on oral cancer therapies [J].
Wood, Leslie .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2012, 16 (04) :432-438
[30]   Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative Study [J].
Iacorossi, Laura ;
Gambalunga, Francesca ;
Fabi, Alessandra ;
Giannarelli, Diana ;
Marchetti, Anna ;
Piredda, Michela ;
De Marinis, Maria Grazia .
CANCER NURSING, 2018, 41 (01) :E57-E63